Recebido em 16/11/2010Aceite para publicação em 16/06/2011 Figura 3. Membros inferiores de M após a resolução das lesões cutâneas
ABSTRACT
A CASE OF ACQUIRED PERFORATING DERMATOSISWe present a case of acquired perforating dermatosis (also known as acquired perforating collagenosis) which is frequently associated with diabetes mellitus and chronic renal failure. A 61 year old diabetic woman had a history of umbilicated, pruritic papules and nodules, with a central keratotic plug, located on the extensor surface of the lower limbs. The diagnosis of acquired perforating dermatosis was made six years after the initial clinical presentation. This article seeks to alert physicians to the existence of this under-diagnosed condition with considerable psychosocial impact.
(± 8,89). Considerando a perda de peso pré-operatória, 63,26% alcançaram uma perda de excesso de peso (EWL) > 30%, com tempo médio internado de 22.28 semanas e velocidade de perda de peso de 1.57 kg/semana. Comparando o sucesso (EWL>50%) da perda de peso total após 1 ano da cirurgia (pré e pós-operatória), os pacientes desse grupo tiveram melhor perda de peso pré-operatória (35.23% vs. 27.98% EWL, p=0.014), maior velocidade de perda de peso pré-operatória (1.62 vs. 1.41 kg/semana, p=0.038) e melhor perda de peso pós-operatória (38.91% vs. 20.09% EWL, p=001). CONCLUSÕES: Em pacientes super-super-obesos, a perda de peso intensiva pré-operatória em ambiente hospitalar tem bons resultados e impacto positivo no resultado final após 1 ano de cirurgia.
ABCDExpress 2017;1(2):430Codigo: 64119 Acesso está disponível em www.revistaabcd.com.br e www.sbad2017.com.br Acesso pelo
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.